CYP3A4 and CYP11A1 variants are risk factors for ischemic stroke: a case control study

Ning Gao1, Hong Tang1, Ling Gao1

  • 1Department of Neurosurgery, Affiliated Haikou Hospital of Xiangya Medical College of Central South University, Haikou People's Hospital, #43, People's Avenue, Haidian Island, Haikou, 570208, Hainan, China.

BMC Neurology
|March 5, 2020
PubMed

Insights

Genetic variants in CYP3A4 and CYP11A1 influence ischemic stroke (IS) risk in the Han Chinese population. Certain CYP3A4 and CYP11A1 polymorphisms may offer protection against IS, while others increase susceptibility.

Area of Science:

  • Genetics
  • Cardiovascular Science
  • Pharmacogenomics

Background:

  • Ischemic stroke (IS) poses a significant health burden.
  • Understanding genetic predispositions is crucial for risk stratification.
  • Cytochrome P450 enzymes, including CYP3A4 and CYP11A1, play roles in various physiological processes.

Purpose of the Study:

  • To investigate the association between specific single-nucleotide polymorphisms (SNPs) in CYP3A4 and CYP11A1 genes and the susceptibility to ischemic stroke.
  • To explore potential sex- and age-specific effects of these genetic variants on IS risk.

Main Methods:

  • A case-control study involving 477 IS patients and 493 healthy controls from the Han Chinese population.
  • Genotyping of seven selected SNPs in CYP3A4 and CYP11A1 using Agena MassARRAY.
  • Statistical analysis using logistic regression to calculate odds ratios (OR) and 95% confidence intervals (CI), adjusted for age and gender.

Main Results:

  • CYP3A4 variants rs3735451 and rs4646440 were associated with a decreased risk of IS.
  • CYP3A4 rs4646440 and CYP11A1 rs12912592 showed associations with IS risk in males.
  • Protective effects of CYP3A4 rs3735451 and rs4646440 were observed in individuals over 61 years old.
  • Specific variants in CYP3A4 and CYP11A1 were linked to IS risk in individuals aged 61 years or younger.
  • CYP11A1 rs28681535 genotype correlated with higher high-density lipoprotein cholesterol levels.

Conclusions:

  • Specific polymorphisms in CYP3A4 (rs3735451, rs4646440, rs4646437) and CYP11A1 (rs28681535) may act as protective factors against ischemic stroke in the Han Chinese population.
  • The CYP11A1 rs12912592 polymorphism was identified as a potential risk factor for IS in this population.
  • These findings highlight the potential role of pharmacogenomic variations in IS susceptibility.
Abstract

Related Concept Videos

Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT01:25

Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT

Calcium-Scoring CT ScanA calcium-scoring CT scan, also known as coronary artery calcium (CAC) scan, detects calcium deposits in the coronary arteries. This test assesses the risk of coronary artery disease (CAD), which can lead to cardiovascular events such as angina, heart failure, and sudden cardiac arrest.A calcium-scoring CT scan is generally recommended for individuals at intermediate risk of CAD without symptoms. It includes:Men aged 40-75 and women aged 50-75: Especially those with a...
309
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
797
Single Nucleotide Polymorphisms-SNPs01:05

Single Nucleotide Polymorphisms-SNPs

A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...
17.8K
Genome-wide Association Studies-GWAS01:11

Genome-wide Association Studies-GWAS

Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
15.2K
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
340
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
538